Catalog ID
PTL-PT141
PT-141 (Bremelanotide)
Melanocortin receptor agonist, 10 mg
PT-141 (bremelanotide), a melanocortin receptor agonist, investigated in central melanocortin signaling, neuroendocrine pathways and sexual-function research models.
Molecular Formula
C50H68N12O10 (reported)
Formula reported in literature; verify against COA.
Purity
≥98%
Molecular Weight
1025.16 g/mol (reported)
Classification
Melanocortin receptor agonist (bremelanotide)
Price
$67.00 – $305.00 USD
Indicative range · converted from USD · free shipping from €500
Pricing tiers · mass & purity
1 vial (10 mg)
$67.00
≥98%
3 vials
$185.00
≥98%
5 vials
$305.00
≥98%
Scientific Background
Bremelanotide (PT-141) is a cyclic heptapeptide melanocortin receptor agonist derived from the melanotan II scaffold, with reported selectivity for MC3R and MC4R. It is studied in neuroscience and neuroendocrine research, with models examining central melanocortin signaling and sexual-function pathways.
Research Focus — Pathways
Central melanocortin (MC3R/MC4R) signaling; neuroendocrine pathways; cAMP-mediated receptor signaling.
Research Areas
- Melanocortin signaling
- MC3R / MC4R signaling
- Sexual function research
- Neuroendocrine signaling
- Central nervous system
Molecular Formula
C50H68N12O10 (reported)
Formula reported in literature; verify against COA.
Molecular Weight
1025.16 g/mol (reported)
Amino Acid Sequence
Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Classification
Melanocortin receptor agonist (bremelanotide)
Research Format
Lyophilized research reagent (10 mg)
Purity
≥98%
Peptide Classification
Melanocortin receptor agonist (bremelanotide)
Sequence Notation
Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Scientific References
The following authoritative sources provide peer-reviewed literature on PT-141 (Bremelanotide). Peptide Hub Biotech World Wide does not claim these sources endorse this product.
Bremelanotide — PubMed literature
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=bremelanotideMelanocortin receptors and behavior — PubMed
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=melanocortin+receptor+behavior
PT-141 (Bremelanotide) — frequently asked
What is PT-141 (Bremelanotide) used for in research?
PT-141 (Bremelanotide) (Melanocortin receptor agonist, 10 mg) is investigated in melanocortin signaling, mc3r / mc4r signaling, sexual function research, neuroendocrine signaling, central nervous system research. Bremelanotide (PT-141) is a cyclic heptapeptide melanocortin receptor agonist derived from the melanotan II scaffold, with reported selectivity for MC3R and MC4R. It is studied in neuroscience and neuroendocrine research, with models examining central melanocortin signaling and sexual-function pathways.
What purity and documentation does PT-141 (Bremelanotide) include?
PT-141 (Bremelanotide) is supplied at ≥98% reported purity as a Lyophilized research reagent (10 mg). A Certificate of Analysis (COA) is available on request with every order.
Does Peptide Hub Biotech World Wide ship PT-141 (Bremelanotide) to the USA, Canada, Europe, Australia and New Zealand?
Yes. Peptide Hub Biotech World Wide ships PT-141 (Bremelanotide) to research customers in the United States, Canada, across Europe, Australia, New Zealand and South American markets. Bulk and wholesale quotes are available via the contact form.
How can I order PT-141 (Bremelanotide)?
Order directly from each product page via our Bitcoin (BTC) checkout — there is no minimum order, and shipping is free on orders from €500 (converted to your local currency). For bulk or wholesale quantities, request a quote through the contact form. After payment, confirm your transaction by email and shipping will proceed.
Related Products
NEWMelanocortin & Pigmentation≥98%Melanotan 2
Synthetic melanocortin receptor agonist studied in melanogenesis and pigmentation-signaling research.
NEWAnti-Aging & Longevity≥97%Somatropin (HGH)
Recombinant human growth hormone (rhGH) studied in growth-hormone signaling and IGF-1 axis research.
Cognitive & Neurological99.3%Semax
Synthetic heptapeptide analogue studied in neuroplasticity and cognitive research.
QC & Quality Systems
Every lot is verified by HPLC and mass-spectrometry purity analysis, peptide-content determination and residual-solvent testing, with a Certificate of Analysis issued per batch — aligned to ISO 9001:2015 and ISO 13485:2016 quality systems, with FDA Drug Master File (DMF) and MDSAP regulatory pathways supported.
ISO 9001:2015
Quality Management System
ISO 13485:2016
Medical Device QMS
FDA DMF
Drug Master File
MDSAP
Medical Device Single Audit Program
Quality & Documentation
Certificate of Analysis available on request · Research Use Only
Request a Quote